10th European Medical Information and Communications Conference and Exhibition

29 - 30 November 2016, Berlin, Germany
The 10th year of the Annual European Medical Information and Communications Conference is a unique meeting organised by medical information professionals for medical information professionals. Each year, speakers share hands-on experience dealing with current challenges as well as successes in medical information departments. Participants are encouraged to take part in the interactive workshop sessions and discussions happening throughout the conference. This conference is the one and only European forum dedicated to medical information and communications, making it the premier opportunity to network, exchange learnings, and share best practices.

Key Topics

  • Moving from traditional phone- and email-based channels to innovative digital channels to disseminate medical information
  • Examples of successes in digital presented by the most advanced players
  • Comparison between pharmaceuticals and medical devices - can the same strategies be used, or is a different approach needed?
  • Regulatory and legal issues: developments since the rejection of Safe Harbor - what's the impact of the new data privacy rules in Europe (Data privacy shield)
  • How to optimise collaboration between MSL and MedInfo roles
  • Effects of globalisation on different roles? How much localisation and how much globalisation is suitable?

Join the Annual European Medical Information and Communications Conference and find answers to issues of daily importance:

  • Are you clear on how to handle questions about off-label use?
  • Do you understand the latest changes in data privacy regulations?
  • Do you know the pros and cons of outsourcing medical information services?
  • How do you ensure high quality when you outsource customer service? Are you not happy with the quality of your outsourced customer services?
  • Is quality an issue in your outsourced medical information function?
  • Is your medical information website getting high enough usage? Learn how to improve hits and increase the number of users.
  • You have develop a website for customer service - now how do you get people to use your site? Is all your effort of building the site going to waste because nobody uses it?
  • How can you be successful in globalising medical information? From a local perspective, how can you best adapt and implement global guidelines?

Call for Poster Abstracts
Become an active part of the conference you attend by presenting a poster. Submit an abstract and take this opportunity to present your research and work to your peers at the conference. It's the perfect place for you to put your research into the limelight, to create discussions around your results with other professionals or to generate interest around a subject you feel needs more attention.

The European Medical Information and Communication Conference stretches across a variety of topics that you have encountered during your work. Contribute to the discussions at the conference by sharing your own experience. Please only submit abstracts matching the following topics:

  • From Safe Harbor to The EU/US Privacy Shield - What do you Need to Know in Medical Information?
  • The Future of Medical Information - Changing Modes of Communication
  • Globalization/Regionalization - Is it Possible to Have one Framework?
  • Medical Information and Medical Scientific Liaisons (MSLs) Partnerships
  • Providing Medical Information for Medical Devices
  • When Medical Information Goes On-line - Optimising the Sharing Experience
  • Considerations, User-Interface and Other Considerations
  • Supporting Established Products in Medical Information
  • Outsourcing and Insourcing Medical Information
  • Medical Information for Challenging Geographies

Deadline: Submit Poster Abstracts by Monday, 26 September 2016.

For further information, please visit:
http://www.diaglobal.org/en/conference-listing/meetings/2016/11/10th-annual-european-medical-information-and-communications-conference-and-exhibition

About DIA
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.

DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, the Middle East, and Africa (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan).

Most Popular Now

Top 20 breaking World Pharma News of 2017

We are proud to announce the top 20 most popular breaking World Pharma News from 2017. Have a wonderful 2018 new(s) year filled with health, happiness, and spectacular su...

Novartis advances head-to-head superiority trials …

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondyl...

Diabetes drug 'significantly reverses memory loss…

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action...

Sandoz regulatory submission for proposed biosimil…

Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics Licen...

Zika remains a research and public health challeng…

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 8...

Try exercise to improve memory, thinking

For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical pract...

Dirt-dwelling microbe produces potential anti-mela…

A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. The molecule is a secondary metabolit...

Novartis Kisqali® received FDA Breakthrough Therap…

Novartis today announced Kisqali® (ribociclib) received US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based treatment of pr...

FDA approves first treatment for breast cancer wit…

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast can...

New research paper shows that AstraZeneca has achi…

In a research paper published today by Nature Reviews Drug Discovery(1), AstraZeneca's IMED Biotech Unit documents a more than four-fold improvement in R&D productivity f...

Berry gives boost to cervical cancer therapy

According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year. One of the most...

Novartis appoints Elizabeth Barrett as Oncology He…

Novartis announced today that Elizabeth (Liz) Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the E...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]